Volpara Health

The Imaging Wire explored the impact of AI (and, more specifically, Lunit’s AI) on improving accuracy, reducing radiologist workload, and fine-tuning algorithms for better performance. Learn how AI is shaping the future of breast cancer screening: https://lnkd.in/dn38MwuW

Think your eyes can beat Lunit Cancer Screening? 🤔 Test yourself compared to Lunit INSIGHT for Breast via an interactive challenge experience. Let us know your results in the comments. 👇 https://lnkd.in/gWzMd2Ar

As the year draws to a close, we wanted to extend warm holiday wishes from Volpara Health to you. Just as the holiday season is about giving, let's unwrap the potential for a prosperous partnership in 2025 that brings abundant benefits to your patients. Volpara's software solutions deliver an array of tools to enhance the overall breast care you provide. Here's to a new year of opportunities, growth, and successful partnership and where we unwrap the best in patient care. Wishing you and your loved ones a season filled with joy, warmth, and moments that sparkle.

Over 25% of patients at Rush University Medical Center are flagged as high-risk for breast cancer—thanks to Volpara® Risk Pathways™. In just two years, 69% of high-risk patients met NCCN Guidelines® for follow-up, leading to earlier detection and improved outcomes. Read how Rush is transforming care with AI: https://lnkd.in/gi9vnSFA

In just 24 months, Singing River Health System reshaped breast cancer care in South Mississippi Using Volpara® Risk Pathways™: ✔️ 25% of patients met NCCN Guidelines® for genetic testing. ✔️ 36% completed the test onsite, identifying 6% with pathogenic mutations or carrier status. ✔️ 42% received negative genetic results but remained at elevated cancer risk, receiving tailored surveillance plans. ✔️ High-risk breast MRI exams increased from 30 to over 200 annually, enabling early cancer detection and proactive care for over 1,800 patients. Learn how they achieved these impressive results: https://lnkd.in/eQYeipcj

Will 2025 be the year you make smarter, more personalized breast care a priority in your organization? Our breast screening software is designed to support your efforts. From personalized risk insights and clinical decision support to improving efficiency with quality analysis, we’re here to help. Let’s start the new year strong—request a demo: https://lnkd.in/gu98SGPQ

Our biggest takeaway from RSNA is that the future is merry and bright for mammography AI in 2025! Watch radiologists discuss how AI is elevating their practice, find out how an integrated ecosystem can advance your breast imaging program, and learn how AdventHealth is reshaping breast cancer risk assessment.  👇

MemorialCare, a participant in the ACR Mammography Positioning Improvement Collaborative, improved mammography metrics from 92% to 96% in six months, reduced variability by 20%, and boosted quality by 13%—all while sustaining excellence with Volpara Analytics. Proud to support MemorialCare in delivering consistent, exceptional care. 👏 Read the full case study to learn more: https://lnkd.in/dV8CvBwQ

One example why events like Radiological Society of North America (RSNA) are so important to advancing the industry and the care patients receive. TRUDY HARRIS, MBA, BSN, RN and her team at Temple University Hospital shared awesome insight with us on their plans for cancer risk assessment. Can't wait to see what they do in 2025 🎉

SecondRead AI is a second set of eyes that gives radiologists AND patients peace of mind.  👀 Watch this quick, real-world use case that led to the discovery and confirmation of a high-risk lesion: https://lnkd.in/gqmkfCFD